Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Capsaicin 750 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Capsaicin |
Inferred relationship |
Some |
|
Capsaicin 250 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Capsaicin |
Inferred relationship |
Some |
|
Product containing capsaicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Capsaicin 179mg/hour transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Capsaicin |
Inferred relationship |
Some |
|
Nonivamide |
Is a |
True |
Capsaicin |
Inferred relationship |
Some |
|
Capsaicin 750 microgram/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Capsaicin 750 microgram/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Capsaicin 250 microgram/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Capsaicin 250 microgram/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Product containing capsaicin in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Capsaicin-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Product containing only capsaicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Product containing only capsaicin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Product containing only capsaicin in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Capsaicin |
Inferred relationship |
Some |
1 |
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Capsaicin |
Inferred relationship |
Some |
1 |